Table 1 |
|||
|
|
|||
|
RS/CSL dominant |
|||
|
|
|||
|
Yes |
No |
Total |
|
|
|
|||
|
Associated pathology |
|||
|
ADH/ALH |
17 |
0 |
17 |
|
In situ |
15 |
9 |
24 |
|
Invasive |
7 |
16 |
23 |
|
Total |
39 |
25 |
64 |
|
|
|||
|
Birchley et al. Breast Cancer Research 2006 8(Suppl 1):P8 doi:10.1186/bcr1423 |
|||